Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo: Blake Nissen for The Boston Globe via Getty Images
Moderna has not been living up to contractual obligations to disclose the percentage of taxpayer dollars that are funding its coronavirus vaccine project, but the pharmaceutical company tells Axios that federal money makes up "100% funding of the program."
Why it matters: Moderna has received almost $1 billion in taxpayer grants to get its vaccine through clinical trials and is considering setting the highest price of all coronavirus vaccine candidates.
Driving the news: Moderna's contract with the Biomedical Advanced Research and Development Authority, which is part of Health and Human Services, includes a provision that requires Moderna to "clearly state ... the percentage of the total costs of the program" financed with federal vs. private dollars.
- Moderna has not done this in any of its press releases tied to its coronavirus vaccine.
- Two consumer advocacy groups, Public Citizen and Knowledge Ecology International, are now pushing HHS to "enforce the provision in this contract and all other applicable contracts."
Between the lines: This provision is commonly called the Stevens Amendment, and it turns out the federal government has done a poor job of enforcing it, according to a Government Accountability Office report from last year.
What they're saying: HHS did not say if it issued Moderna an exemption from this provision, only saying in a response:
- "Moderna provides the required acknowledgement to the federal government for funding and other support provided to develop the vaccine. The company would need to identify for you what percentage of this specific contract is federally funded. We continue to collaborate with companies as they put out press releases to ensure accurate information."
Moderna said in multiple responses that it "request[s] BARDA review for each of our press releases or other disclosures before we issue ... and are comfortable that the information included in our public disclosures is consistent with BARDA's expectations."
- Moderna said the language in its original BARDA funding press release — "BARDA will fund the advancement of mRNA-1273 to FDA licensure" — "made clear the extent of BARDA's 100% funding of the program."